Point-of-Care Glucose Testing Market to Grow at 4.20% CAGR through 2029

Increasing prevalence of diabetes and rise of continuous glucose monitoring (CGM) is expected to drive the Global Point-of-Care Glucose Testing Market growth in the forecast period, 2025-2029. 

According to TechSci Research report, “Point-of-Care Glucose Testing Market – Global Industry Size, Share, Trends, Competition, Forecast & Opportunities, 2029F”, the Global Point-of-Care Glucose Testing Market stood at USD 3.30 billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 4.20% through 2029. The growth of the Global Point-of-Care Glucose Testing Market is primarily fueled by several factors, including the increasing prevalence of diabetes, the demand for portable and convenient testing devices, and advancements in technology allowing for faster and more accurate glucose measurements. The growing emphasis on preventive healthcare is contributing to market expansion.

The market for point-of-care glucose testing is experiencing a dynamic and evolving landscape, driven by technological advancements, the rising prevalence of diabetes, and a greater focus on efficient healthcare delivery. With diabetes rates on the rise globally, there is a corresponding increase in demand for point-of-care glucose testing solutions. These solutions offer rapid and convenient monitoring of blood glucose levels, facilitating timely interventions and improved disease management. The market encompasses a variety of products, including glucose meters, test strips, lancets, and continuous glucose monitoring systems, each catering to the specific needs and preferences of healthcare professionals and patients alike. The integration of advanced technologies such as wireless connectivity, smartphone compatibility, and cloud-based data management systems has further enhanced the functionality and usability of these devices, enabling seamless remote monitoring and data sharing.

Key players in the Global Point-of-Care Glucose Testing Market are actively involved in product innovation and strategic collaborations to maintain a competitive edge and expand their market presence. Research and development efforts are focused on improving the accuracy, reliability, and user-friendliness of glucose testing devices, while also addressing evolving regulatory requirements and quality standards. Partnerships with healthcare providers, insurance companies, and digital health platforms aim to streamline patient care pathways, enhance access to testing services, and promote better adherence to treatment protocols. The rise of telemedicine and telehealth solutions has opened up new opportunities for remote patient monitoring and virtual consultations, further driving the adoption of point-of-care glucose testing solutions in homecare settings and ambulatory care facilities.

The Global Point-of-Care Glucose Testing Market is expected to continue growing and innovating, driven by evolving patient needs, technological advancements, and healthcare reforms aimed at improving care quality and reducing costs. Key trends shaping the market include the integration of artificial intelligence and machine learning for predictive analytics and personalized disease management, the emergence of wearable glucose monitoring devices for continuous real-time monitoring, and the convergence of glucose testing with other vital signs monitoring parameters for comprehensive health assessment. The ongoing COVID-19 pandemic has underscored the importance of point-of-care testing in enabling rapid diagnosis and monitoring of infectious diseases, further boosting the demand for versatile and scalable testing solutions. In conclusion, the Global Point-of-Care Glucose Testing Market presents significant opportunities for innovation and growth, driven by the imperative to transform healthcare delivery and improve patient outcomes globally.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Point-of-Care Glucose Testing Market” 

The Global Point-of-Care Glucose Testing Market is segmented into product type, regional distribution, and company.

Based on product type, Accu-Chek Inform II segment is anticipated to experience the fastest growth in the forecast period. The Accu-Chek II product line has earned a solid reputation for its accuracy, reliability, and user-friendly design, making it the preferred choice for both healthcare professionals and patients. Its consistent performance and dependable results have built trust and confidence, leading to widespread acceptance across various healthcare environments. Roche, the company behind Accu-Chek, has continuously invested in research and development to improve product features and functionalities, staying ahead of competitors and maintaining its leadership position in the market.

The Accu-Chek Inform II segment benefits from a well-established distribution network and extensive market coverage, facilitating efficient product distribution and access to a diverse global customer base. Strategic collaborations with healthcare providers, insurance companies, and digital health platforms have further bolstered its market presence and facilitated seamless integration into existing healthcare workflows. The company's dedication to customer support, education, and training initiatives has played a vital role in driving user adoption and ensuring the optimal use of Accu-Chek II devices.

Based on region, the North America region has experienced the rapid growth in 2023 due to a combination of factors that collectively foster a conducive environment. North America possesses a robust healthcare infrastructure characterized by advanced medical facilities, well-established regulatory frameworks, and high healthcare expenditure. These factors collectively contribute to the widespread adoption of point-of-care glucose testing solutions in the region. With a significant population affected by diabetes, prevalence rates have steadily risen over the years, fueling the demand for efficient and convenient glucose monitoring devices. North America is home to leading market players who continuously focus on innovation and product development, solidifying the region's leadership position. These companies leverage cutting-edge technologies, strategic collaborations, and extensive distribution networks to meet the diverse needs of healthcare providers and patients.

Government bodies and healthcare organizations in North America have also initiated various programs to promote preventive care, chronic disease management, and early intervention strategies, further boosting the uptake of point-of-care glucose testing solutions across different healthcare settings. North America remains at the forefront of innovation and growth in the global point-of-care glucose testing market, serving as a model of excellence and a significant driver of market expansion worldwide.

Major companies operating in Global Point-of-Care Glucose Testing Market are:

• F. Hoffmann-La Roche Ltd
• Abbott Laboratories Inc.
• Nipro Corporation
• Lifescan, Inc.
• Nova Biomedical Corporation
• ACON Laboratories Inc.
• Trividia Health, Inc.
• Prodigy Diabetes Care, LLC
• Ascensia Diabetes Care Holdings AG
• EKF Diagnostics Holdings PLC

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The future of the Point-of-Care Glucose Testing Market is marked by innovation and technological advancement to improve patient outcomes and healthcare delivery. With diabetes rates rising globally, there's a growing demand for more efficient, accurate, and user-friendly glucose testing solutions that integrate seamlessly into patients' lives for personalized disease management. Industry stakeholders are expected to utilize emerging technologies such as artificial intelligence and wearable sensors to develop next-generation monitoring devices capable of real-time monitoring and predictive analytics. Telemedicine and remote patient monitoring integration will revolutionize glucose testing, enabling seamless data sharing and remote consultations to expand access to testing services and improve care coordination. Collaborations between industry players, healthcare providers, and digital health platforms will drive the development of integrated healthcare ecosystems prioritizing patient-centric care and data-driven decision-making”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Point-of-Care Glucose Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer CONTOUR Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip, Others), By Region, and Competition, 2019-2029F”, has evaluated the future growth potential of Global Point-of-Care Glucose Testing Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Point-of-Care Glucose Testing Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com